You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 4,889,806


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,889,806
Title: Large DNA cloning system based on yeast artificial chromosomes
Abstract:A large DNA cloning system is disclosed which is based on yeast artificial chromosomes. Cloning vectors are disclosed which allow the cloning of large segments of greater than 50 kb of exogenous DNA. The cloning vector comprises DNA sequences of an autonomous replication sequence, a centromere, a selectable yeast marker, two sequences that seed telomere function in vivo, and a cloning site within an interruptible yeast gene for insertion of the exogenous DNA segments.
Inventor(s): Olson; Maynard V. (St. Louis, MO), Burke; David T. (St. Louis, MO)
Assignee: Washington University (St. Louis, MO)
Application Number:07/038,280
Patent Claims:1. A Saccharomyces yeast artificial chromosome circular vector comprising the DNA sequences of an autonomous replication sequence, a centromere, a selectable yeast marker, two sequences that seed telomere formation in vivo, and a cloning site for insertion of large segments of greater than 50 kb of exogenous DNA within a yeast gene whose interruption is phenotypically visible.

2. A Saccharomyces yeast artificial chromosome circular vector comprising the DNA sequences of an autonomous replication sequence, a centromere, selectable yeast markers on both sides of the centromere, two sequences that seed telomere formation in vivo separated by a throw-away sequence, and a cloning site for insertion of large segments of greater than 50 kb of exogenous DNA within a yeast gene whose interruption is phenotypically visible.

3. The vector of claim 2 in which the yeast gene with the cloning site is SUP4.

4. The vector of claim 3 in which the cloning site is Sma I.

5. The vector of claim 2 in which the selectable yeast markers are TRP1 and URA3.

6. The vector of claim 2 in which the throw-away sequence is HIS3.

7. The vector of claim 2 in which Xho I sites are centromere-proximal to each of the telomere formation sequences.

8. The vector of claim 2 including the origin of DNA replicon (ori) and the ampicillin resistance gene (Amp) of a bacterial plasmid to allow replication in bacteria.

9. The vector of claim 3 in which the cloning site is in the SUP4 gene's basepair intron.

10. The vector of claim 9 in which the cloning site is SnaB I.

11. The vector of claim 10 in which the Sfi I and Not I sites flanking the SUP4 gene are deleted.

12. The vector of claim 10 in which an EcoR I linker is inserted into the SnaB I site.

13. Plasmid pYAC2.

14. Plasmid pYAC4.

15. Sacchromyces cerevisiae cells transformed with the plasmid of claim 13 ligated to a segment of greater than 50 kb of exogenous DNA.

16. Saccharomyces cerevisiae cells transformed with the plasmid of claim 14 ligated to a segment of greater than 50 kb of exogenous DNA.

17. The cells of claim 15 in which the host strain is AB1380.

18. The cells of claim 16 in which the host strain is AB1380.

19. The method of producing a yeast artificial chromosome comprising cleaving a vector as defined in claim 1 with selected restriction endonucleases to form a left chromosome arm including the centromere and the autonomous replication sequence, and a right chromosomal arm, and then ligating said arms onto a large exogenous DNA insert molecule of greater than 50 kb.

20. The method of producing a yeast artificial chromosome comprising cleaving plasmid pYAC2 with BamH I and Sma I restriction endonucleases to form a left chromosome arm including the centromere and the autonomous replication sequence, a right chromosomal arm, and a throw-away sequence, treating said arms with alkaline phosphatase to prevent religation and then ligating said arms onto a large exogenous DNA inset molecule of greater than 50 kb having Sma I compatible ends.

21. The method of producing a yeast artificial chromosome comprising cleaving plasmid pYAC4 with BamH I and EcoR I restriction endonucleases to form a left chromosome arm including the centromere and the autonomous replication sequence, a right chromosomal arm, and a throw-away sequence, treating said arms with alkaline phosphatase to prevent religation and the ligating said arms onto a large exogenous DNA insert molecule of greater than 50 kb having SnaB I compatible ends.

Details for Patent 4,889,806

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2039-02-26
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.